"Dr. Brian Miller is an Electrophysiologist in Springfield, IL. He is affiliated with Prairie Heart, the top cardiology practice in IL."

During the past decade, Prairie Heart Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prairie Heart Institute" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "BridgePoint Medical" with 2 trials sponsored, "Medtronic Vascular" with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prairie Heart Institute" #1 collaborator was "Boston Scientific Corporation" with 2 trials as a collaborator, "The Cleveland Clinic" with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "C. R. Bard" with 1 trials as a collaborator and "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Prairie Heart Institute" are "Heart Failure" (4 trials), "Cardiovascular Diseases" (3 trials), "Heart Diseases" (2 trials), "Paroxysmal Atrial Fibrillation" (2 trials) and "Peripheral Vascular Disease" (2 trials). Many other conditions were trialed in "Prairie Heart Institute" in a lesser frequency.

Most popular intervention types in "Prairie Heart Institute" are "Device" (14 trials), "Drug" (7 trials), "Other" (5 trials), "Procedure" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ad2/HIF-1α/VP16" (1 trials), "Adherence Counseling" (1 trials), "Angioplasty" (1 trials), "Atorvastatin" (1 trials) and "Bococizumab (PF-04950615;RN316)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prairie Heart Institute" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Prairie Heart Institute". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Prairie Heart Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Prairie Heart Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".